|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Intangible asset amortization | |||||
| Restructuring, impairment and extinguishment costs | |||||
| Business separation costs | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Indemnification Agreement expense | |||||
| Other expense (income), net | |||||
| Interest expense, net | |||||
| Net income (loss) before taxes | |||||
| Provision for income taxes | |||||
| Net income (loss) | |||||
| Less: preferred stock dividends | |||||
| Less: undistributed income allocated to preferred stockholders | |||||
| Net income (loss) available to common stockholders, basic | |||||
| Net income (loss) available to common stockholders, diluted | |||||
| Earnings (loss) per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Weighted average basic number of common shares outstanding (in shares) | |||||
| Diluted (in shares) | |||||
Loading...